Details of the Drug Combination

General Information of Drug Combination (ID: DCNA2UX)

Drug Combination Name
Felypressin Prilocaine
Indication
Disease Entry Status REF
Overcoming the Failure of Anaesthesia Phase 4 [1]
Component Drugs Felypressin   DMHLP9C Prilocaine   DMI7DZ2
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL is unavailable 3D MOL

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Felypressin
Disease Entry ICD 11 Status REF
Localisation N.A. Approved [2]
Felypressin Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Vasopressin V1a receptor (V1AR) TT4TFGN V1AR_HUMAN Agonist [5]
------------------------------------------------------------------------------------
Indication(s) of Prilocaine
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Approved [3]
Premature ejaculation HA03.0Z Investigative [4]
Prilocaine Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Voltage-gated sodium channel alpha Nav1.5 (SCN5A) TTZOVE0 SCN5A_HUMAN Blocker [6]
------------------------------------------------------------------------------------
Prilocaine Interacts with 3 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Interleukin-6 (IL6) OTUOSCCU IL6_HUMAN Increases Expression [7]
RAC-alpha serine/threonine-protein kinase (AKT1) OT8H2YY7 AKT1_HUMAN Increases Phosphorylation [7]
Nitric oxide synthase, inducible (NOS2) OTKKIOJ1 NOS2_HUMAN Increases Expression [7]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04236115) Comparison of Articaine and Prilocaine for Extraction of Maxillary Teeth
2 Drug Therapy in Nursing. 2008. By Diane S. Aschenbrenner, Samantha J. Venable.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7276).
4 Prilocaine FDA Label
5 Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res. 2008;170:473-512.
6 Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12.
7 Inflammatory signal transduction pathways induced by prilocaine toxicity in cultured ARPE-19 cells. J Biochem Mol Toxicol. 2023 Dec;37(12):e23491. doi: 10.1002/jbt.23491. Epub 2023 Aug 10.